The non-canonical functions of p27Kip1 in normal and tumor biology

SS Sharma, WJ Pledger - Cell Cycle, 2016 - Taylor & Francis
ABSTRACT p27Kip1 was first discovered as a key regulator of cell proliferation. The
canonical function of p27Kip1 is inhibition of cyclin-dependent kinase (CDK) activity. In …

Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy

S Vakili-Samiani, OJ Khanghah, E Gholipour… - Mutation Research …, 2022 - Elsevier
Mitosis is the process of cell division and is regulated by checkpoints in the cell cycle. G1-S,
S, and G2-M are the three main checkpoints that prevent initiation of the next phase of the …

Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer

F Citron, I Segatto, GLR Vinciguerra, L Musco, F Russo… - Cancer research, 2020 - AACR
Abstract miR-223 is an anti-inflammatory miRNA that in cancer acts either as an
oncosuppressor or oncopromoter, in a context-dependent manner. In breast cancer, we …

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation

A Dall'Acqua, M Sonego, I Pellizzari… - EMBO molecular …, 2017 - embopress.org
Epithelial ovarian cancer (EOC) is an infrequent but highly lethal disease, almost invariably
treated with platinum‐based therapies. Improving the response to platinum represents a …

Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments

R Biaoxue, C Xiguang, L Hua, Y Shuanying - Journal of translational …, 2016 - Springer
Abstract Knowledge of the molecular mechanisms on malignant tumors is very critical for the
development of new treatment strategies like molecularly targeted therapies. In last 5 years …

p27Kip1 and human cancers: A reappraisal of a still enigmatic protein

D Bencivenga, I Caldarelli, E Stampone, FP Mancini… - Cancer letters, 2017 - Elsevier
Abstract p27 Kip1 is a cell cycle regulator firstly identified as a cyclin-dependent kinase
inhibitor. For a long time, its function has been associated to cell cycle progression inhibition …

Autoregulation and repair in microtubule homeostasis

I Gasic, TJ Mitchison - Current opinion in cell biology, 2019 - Elsevier
Even in the face of damaging insults, most cells maintain stability over time through multiple
homeostatic pathways, including maintenance of the microtubule cytoskeleton that is …

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells

M Sonego, I Pellizzari, A Dall'Acqua, E Pivetta… - Scientific reports, 2017 - nature.com
Standard of care for Epithelial Ovarian Cancer (EOC) patients relies on platinum-based
therapy. However, acquired resistance to platinum occurs frequently and predicts poor …

p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation

N Li, J Zeng, F Sun, X Tong, G Meng, C Wu, X Ding… - Cell Cycle, 2018 - Taylor & Francis
ABSTRACT p27 plays critical roles in cell proliferation, differentiation, and apoptosis, which
have been well studied in mammals and Drosophila. However, the mechanisms underlying …

p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability

L Fabris, S Berton, I Pellizzari… - Proceedings of the …, 2015 - National Acad Sciences
The cyclin-dependent kinase (CDK) inhibitor p27kip1 is a critical regulator of the G1/S-
phase transition of the cell cycle and also regulates microtubule (MT) stability. This latter …